Fingerprint
Dive into the research topics of 'Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically